177 related articles for article (PubMed ID: 798273)
21. [Treatment with antiplatelet drugs. Current status of knowledge].
Dettori AG; Pini M; Quintavalla R
Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
[No Abstract] [Full Text] [Related]
22. Antiplatelet agents: a review.
Gantmacher ML
J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
[No Abstract] [Full Text] [Related]
23. Acetylsalicylic acid, hemostasis and human thromboembolism.
Jobin F
Semin Thromb Hemost; 1978; 4(3):199-240. PubMed ID: 204999
[No Abstract] [Full Text] [Related]
24. The role of platelets in thrombotic and vascular disease.
Schafer AI; Handin RI
Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
[No Abstract] [Full Text] [Related]
25. Antiplatelet drugs in arterial thrombosis: a review.
Tsu EC
Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
[TBL] [Abstract][Full Text] [Related]
26. [Aspirin as a platelet antiaggregant: indications and controversies].
Stalder M; Bachmann F
Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789
[No Abstract] [Full Text] [Related]
27. [Indications and uncertainties of antiaggregating agents].
Verstraete M
Rev Prat; 1977 Dec; 27(57):3999-4005. PubMed ID: 345400
[No Abstract] [Full Text] [Related]
28. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
29. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
30. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Hansen MS; Birgens HS
Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
[No Abstract] [Full Text] [Related]
31. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
32. [Effect of aspirin and clofibrate on the metabolism and hemostatic functions of blood platelets].
Stachecki B; Kotelba-Witkowska B; Chmiel J; Olszewska K; Malanowicz W; Górecka R
Acta Haematol Pol; 1982; 13(3-4):103-17. PubMed ID: 7184294
[No Abstract] [Full Text] [Related]
33. Clinical pharmacology of anti-aggregating substances.
Vermylen J
Acta Clin Belg; 1975; 30(3):204-9. PubMed ID: 1231459
[No Abstract] [Full Text] [Related]
34. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
35. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
Wang ZG; McCann RL; Hagen PO
Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
[No Abstract] [Full Text] [Related]
36. [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study].
Yoshii K; Seki Y; Aiba T; Tsukada T; Shiozawa R
No To Shinkei; 1985 Oct; 37(10):985-90. PubMed ID: 4074576
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacology of platelets.
Packham MA; Mustard JF
Blood; 1977 Oct; 50(4):555-73. PubMed ID: 332253
[No Abstract] [Full Text] [Related]
39. Platelet kinetics--1975.
Ries CA
Ser Haematol; 1975; 8(3):98-104. PubMed ID: 1234386
[TBL] [Abstract][Full Text] [Related]
40. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(24):1236-40. PubMed ID: 1102983
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
